Please assess the completion status of the following clinical trial:

Trial Title: Microwave Ablation for Uterine Fibroids

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~1. Symptomatic fibroids with or without focal adenomyoma~2. Female gender~3. Age between 30 and 50~4. Pre or peri menopausal with FSH less than 40 mIU/ml~5. Negative urine pregnancy test~6. Uterine size less than 22 weeks based on physical exam assessment~7. Dominant intramural fibroid greater than or equal to 3 cm and less than or equal to 10 cm on imaging.~8. Good health other than history of leiomyomas. Chronic medications may be acceptable at the discretion of the research team.~9. Are using abstinence, mechanical (condoms, diaphragms) or sterilization methods of contraception and are willing to continue using them throughout the study.~10. Willing and able to give informed consent.~11. Willing and able to comply with study requirements.~12. Normal menstrual cycle with endometrial pathology excluded~Exclusion Criteria:~1. History of or current thromboembolic event (deep vein thrombosis, pulmonary embolus, stroke)~2. Other pelvic pathology as indicated by history or MR imaging such as endometriosis, ovarian tumor, acute or chronic pelvic inflammatory disease~3. Pregnant or Positive pregnancy test~4. Unexplained vaginal bleeding~5. Untreated severe cervical dysplasia~6. Abnormal adnexal /ovarian mass~7. Intrauterine device~8. Known recent rapid growth of fibroids, defined as a doubling in size in 6 months~9. Known bleeding tendency~10. Contraindication to MRI due to severe claustrophobia or implanted metallic device.

- Gender: FEMALE
- Minimum Age: 30 Years
- Maximum Age: 50 Years
- Healthy Volunteers: f

Study Arms:
- Microwave ablation (Type: OTHER): The uterine fibroid will be identified and located with ultrasonography. A microwave electrode appropriate for the size of target lesion is placed into the target lesion under ultrasound guidance. Appropriate microwave power and application time are selected to provide sufficient ablation coverage to the target lesion.

Based on this trial design, predict the completion outcome and termination type (if applicable).